Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 20

- Webcast Available Through Gilead Corporate Website -

FOSTER CITY, Calif., Sep 13, 2010 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the UBS Global Life Sciences Conference in New York.

John C. Martin, PhD, Gilead's Chairman and Chief Executive Officer, will provide an overview of the company on Monday, September 20 at 1:00 p.m. Eastern Daylight Time.

To access the live webcast via the internet log on to http://www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O'Brien, 650-522-1936
Investor Relations